Molekulyarnaya Meditsina (Molecular medicine),
Journal Year:
2024,
Volume and Issue:
unknown, P. 31 - 40
Published: Nov. 6, 2024
Introduction.
Artificial
intelligence
(AI)
technologies
are
becoming
crucial
in
clinical
diagnostics
due
to
their
ability
process
and
interpret
large
volumes
of
data.
The
implementation
AI
for
biomarker
analysis
opens
new
opportunities
personalized
medicine,
offering
more
accurate
individualized
approaches
disease
diagnosis
treatment.
relevance
this
review
stems
from
the
need
systematize
recent
advances
application
analysis,
which
is
critical
early
prediction
chronic
non-communicable
diseases
(NCDs).
Material
methods.
peer-reviewed
scientific
publications
reports
leading
research
centers
over
past
five
years
was
conducted.
Studies
on
algorithms
analyzing
genomic,
proteomic,
metabolomic
biomarkers
were
reviewed,
including
machine
learning
methods
deep
neural
networks.
Special
attention
paid
integration
multi-marker
panels
improving
accuracy
cardiovascular,
digestive,
respiratory,
endocrine
system
diseases,
as
well
oncological
neurodegenerative
pathologies.
Results.
has
significantly
increased
sensitivity
specificity
diagnostics,
especially
complex
cases
requiring
multiple
parameters.
effectiveness
been
demonstrated
lung,
breast,
colorectal
cancer,
cardiovascular
complications
NCDs
progression,
diabetes
mellitus
Alzheimer’s
disease.
AI’s
significant
contribution
discovery
biomarkers,
optimization
treatment,
improvement
therapeutic
strategies
noted.
Conclusion.
use
become
a
breakthrough
medical
particularly
oncology,
cardiology,
diseases.
technology
allows
data
about
various
contributes
creating
models
prediction.
Further
development
associated
with
advancement
overcoming
ethical
regulatory
barriers,
will
expand
capabilities
practice.
Journal of Cancer Metastasis and Treatment,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 10, 2025
Electronic
Nose
(E-Nose)
technology
has
emerged
as
a
transformative
tool
in
medical
diagnostics,
leveraging
sensor
arrays
that
mimic
the
human
olfactory
system
to
detect
odors
and
volatile
organic
compounds
(VOCs)
various
biological
samples.
E-Nose
systems
utilize
range
of
types,
such
metal
oxide
semiconductors
conducting
polymers,
generate
unique
“smell
fingerprints”
through
pattern
recognition
algorithms.
These
have
shown
promise
diagnosing
conditions,
including
respiratory
diseases,
infectious
metabolic
disorders,
neurological
conditions.
Notably,
holds
significant
cancer
offering
non-invasive,
cost-effective,
rapid
approach
early
detection
monitoring.
It
demonstrated
impressive
accuracy
(85%-95%)
detecting
cancers
monitoring
complications.
However,
challenges
remain,
issues
with
standardization,
sensitivity,
data
interpretation.
Despite
these
hurdles,
technology’s
market
growth
is
fueled
by
increasing
prevalence
chronic
diseases.
Recent
developments
Artificial
Intelligence
(AI),
particularly
machine
learning
techniques
like
deep
learning,
enhanced
diagnostic
robustness
devices.
This
paper
explores
evolution,
core
principles,
applications,
challenges,
future
potential
technology,
particular
emphasis
on
integrating
recent
advancements
AI
for
Future
research
collaboration
across
sectors
are
essential
overcome
existing
integrate
into
mainstream
healthcare.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 11, 2025
Lung
cancer,
particularly
adenocarcinoma,
ranks
high
in
morbidity
and
mortality
rates
worldwide,
with
a
relatively
low
five-year
survival
rate.
To
achieve
precise
prognostic
assessment
clinical
intervention
for
patients,
thereby
enhancing
their
prospects,
there
is
an
urgent
need
more
accurate
stratification
schemes.
Currently,
the
TNM
staging
system
predominantly
used
practice
evaluation,
but
its
accuracy
constrained
by
reliance
on
physician
experience.
Although
biomarker
discovery
based
molecular
pathology
offers
new
perspective
assessment,
dependence
expensive
gene
panel
testing
limits
widespread
application.
Pathological
images
contain
abundant
diagnostic
information,
providing
avenue
evaluation.
In
this
study,
we
employed
advanced
Hover-Net
technology
to
accurately
quantify
abundance
of
epithelial
cells,
lymphocytes,
macrophages,
neutrophils
from
pathological
images,
delved
into
biological
significance
these
cellular
abundances.
Our
research
findings
reveal
that,
contrast
patients
classified
as
N0
stage,
those
belonging
N1
stage
demonstrated
marked
elevation
infiltration
neutrophils.
Notably,
patterns
lymphocytes
exhibited
inverse
relationship
activation
status
numerous
pivotal
pathways,
including
HALLMARK_HEME_METABOLISM
pathway.
Furthermore,
our
analysis
distinguished
FABP7
biomarker,
exhibiting
pronounced
differential
expression
between
levels
neutrophil
infiltration,
indicate
that
can
provide
cost-effective
offering
strategies
management
lung
adenocarcinoma.
International Journal of Scientific Research in Science and Technology,
Journal Year:
2025,
Volume and Issue:
12(1), P. 268 - 275
Published: Jan. 30, 2025
This
study
aims
to
develop
an
in-house
phantom
that
can
more
cheaply
represent
pediatric
lung
cancer
cases.
The
materials
used
in
this
were
polymethyl
methacrylate
(PMMA)
as
a
substitute
for
soft
tissue,
polyurethane
(PU)
foam
and
calcium
carbonate
replacement
rib
bones.
Cancer
or
nodules
represented
using
beeswax.
evaluation
was
conducted
IndoQCT
software,
with
parameters
such
CT
number,
noise,
signal-to-noise
ratio
(SNR),
contrast-to-noise
(CNR).
numbers
of
cancer/nodule,
normal
lung,
bone
the
are
-217
-117,
-979,
80,
871
HU,
respectively.
As
comparison,
number
real
patients
-141
-103,
-906,
73,
743
These
findings
indicate
SNR,
CNR
values
closely
resemble
imaging
cancer/nodules.
Thus,
effectively
human
tissue
substitutes.
Applied Sciences,
Journal Year:
2025,
Volume and Issue:
15(9), P. 4637 - 4637
Published: April 22, 2025
Lung
cancer
is
a
major
global
health
threat,
affecting
millions
annually
and
resulting
in
severe
complications
high
mortality
rates,
particularly
when
diagnosed
late.
It
remains
one
of
the
leading
causes
cancer-related
deaths
worldwide,
often
detected
at
advanced
stages
due
to
lack
early
symptoms.
This
study
introduces
novel
hybrid
machine
learning
model
aimed
enhancing
detection
accuracy
improving
patient
outcomes.
By
integrating
traditional
classifiers
with
deep
techniques,
proposed
framework
optimizes
feature
selection,
hyperparameter
tuning,
data-balancing
strategies,
such
as
Adaptive
Synthetic
Sampling
(ADASYN).
A
comparative
evaluation
existing
models
demonstrated
substantial
improvements
predictive
accuracy,
ranging
from
0.44%
9.69%,
Gradient
Boosting
Random
Forest
achieving
highest
classification
performance.
The
highlights
importance
methodologies
refining
lung
diagnostics,
ensuring
robust,
scalable,
clinically
viable
models.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(2), P. e0316136 - e0316136
Published: Feb. 24, 2025
Lung
cancer
remains
a
leading
cause
of
cancer-related
deaths
worldwide,
with
low
survival
rates
often
attributed
to
late-stage
diagnosis.
To
address
this
critical
health
challenge,
researchers
have
developed
computer-aided
diagnosis
(CAD)
systems
that
rely
on
feature
extraction
from
medical
images.
However,
accurately
identifying
the
most
informative
image
features
for
lung
detection
significant
challenge.
This
study
aimed
compare
effectiveness
both
hand-crafted
and
deep
learning-based
approaches
We
employed
traditional
features,
such
as
Gray
Level
Co-occurrence
Matrix
(GLCM)
in
conjunction
machine
learning
algorithms.
explore
potential
learning,
we
also
optimized
implemented
Bidirectional
Long
Short-Term
Memory
(Bi-LSTM)
network
detection.
The
results
revealed
highest
performance
using
was
achieved
by
extracting
GLCM
utilizing
Support
Vector
Machine
(SVM)
different
kernels,
reaching
an
accuracy
99.78%
AUC
0.999.
Bi-LSTM
surpassed
methods,
achieving
99.89%
1.0000.
These
findings
suggest
proposed
methodology,
combining
holds
promise
enhancing
early
ultimately
improving
systems.